Company intelligence / Profile preview

Berlin Heart

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Berlin Heart develops and markets mechanical circulatory support devices—primarily the paracorporeal EXCOR® VAD system—for both adults and children with end-stage heart failure. The company’s flagship product, EXCOR® Pediatric, remains the only FDA-approved VAD for infants and small children as a bridge to transplant or recovery. Clinical studies have demonstrated improved outcomes for pediatric patients supported by the device prior to transplantation.

Therapeutic areas: Cardiovascular
Modalities: DeviceMechanical circulatory support systemVentricular assist device (VAD)
Industry: Therapeutic Medical Devices

Partnerships

Strategic partnerships with leading global centers including German Heart Institute BerlinHospital for Sick Kids TorontoTexas Children’s Hospital Houston

Beyond the preview

Go deeper on Berlin Heart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Berlin Heart.

Explore the full profile